Text Size

A A A

Search
 

Home | Clinical Trials

FDA Approved Drugs » 1998
Medical Areas: Neurology | Family Medicine | Genetic Disease

View By:Year | Company | Conditions | Therapeutic Areas | Drug Names

Lamictal Chewable Dispersible Tablets

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: GlaxoSmithKline
Approval Status: Approved August 1998
Treatment Area: Epilepsy

General Information

Lamictal tablets are used for the treatment of Lennox-Gastaut syndrome seizures of patients with severe forms of epilepsy.


 Back to Top | Printer Friendly Version

Get Involved

Stroke and You

Resources

 

Our Mission Statement

National Stroke Association’s mission is to reduce the incidence and impact of stroke by developing compelling education and programs focused on prevention, treatment, rehabilitation and support for all impacted by stroke.

 

Visit Our Online Store

National Stroke Association

1-800-STROKES
1-800-787-6537
9707 E. Easter Lane, Suite B
Centennial, CO 80112
info@stroke.org



© Copyright 2011 National Stroke Association, All Rights Reserved. Unauthorized Use is Prohibited.


+ Dial 911 In case of emergency +

About Us · Board · Press · Contact · Privacy Policy